v3.26.1
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2026
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
The following table describes for the quarterly period covered by this report each trading arrangement for the purchase or sale of the Company’s securities adopted, modified or terminated by our directors and officers that is either (1) a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), or a “Rule 10b5-1 trading arrangement,” or (2) a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K):
Name (Title)Action Taken (Date of Action)Type of Trading ArrangementNature of Trading ArrangementDuration of Trading ArrangementAggregate Number of Securities
Chan Lee
(Senior Vice President, General Counsel)
Adoption
(May 29, 2026)
Rule 10b5-1 trading arrangementSale
August 28, 2027
Up to 9,353 ADSs plus up to such additional number of ADSs subject to restricted share units (“RSUs”) equal to the net number of ADSs resulting from applicable RSU vestings after sell-to-cover for withholding tax.
Dr. Xiaodong Wang
(Co-Founder and Director)
Adoption
(June 9, 2026)
Rule 10b5-1 trading arrangementSale
September 8, 2027
Stock options and RSUs equaling up to 131,370 ADSs.
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Chan Lee [Member]  
Trading Arrangements, by Individual  
Name Chan Lee
Title Senior Vice President, General Counsel
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 29, 2026
Expiration Date August 28, 2027
Arrangement Duration 456 days
Aggregate Available 9,353
Dr. Xiaodong Wang [Member]  
Trading Arrangements, by Individual  
Name Dr. Xiaodong Wang
Title Co-Founder and Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 9, 2026
Expiration Date September 8, 2027
Arrangement Duration 456 days
Aggregate Available 131,370